Brind.

Johnson & Johnson announced the winding down of a legacy catheter relationship and maintained its 'Market Outperform' rating on Stereotaxis, Inc.

1 report, 1 independent Updated Jun 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Johnson & Johnson Citizens

Keep exploring

The entities involved

Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
Citizens
Chilean political party
- Citizens and First Bank were identified as small-cap finance companies.Sat 03:58
- Citizens policyholders are affected by new insurance rules in Central Florida.Fri 23:03

Coverage

Newest first; wire copies grouped

Jun 29insidermonkey.com